dexmedetomidine has been researched along with Protein Aggregation, Pathological in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bretteville, A; El Khoury, N; Gratuze, M; Marcouiller, F; Morin, F; Noël, A; Papon, MA; Petry, FR; Planel, E; Poitras, I; Truchetti, G; Virág, L; Whittington, RA; Wong, K | 1 |
1 other study(ies) available for dexmedetomidine and Protein Aggregation, Pathological
Article | Year |
---|---|
Dexmedetomidine increases tau phosphorylation under normothermic conditions in vivo and in vitro.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Cells, Cultured; Dexmedetomidine; Dose-Response Relationship, Drug; Hippocampus; Humans; Hypnotics and Sedatives; Hypothermia, Induced; In Vitro Techniques; Infusions, Intravenous; Mice, Inbred C57BL; Phosphorylation; Protein Aggregation, Pathological; Spatial Memory; tau Proteins | 2015 |